piracetam has been researched along with Coronary Artery Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uebelhack, R | 1 |
| Vohs, K | 1 |
| Zytowski, M | 1 |
| Schewe, HJ | 1 |
| Koch, C | 1 |
| Konertz, W | 1 |
1 trial available for piracetam and Coronary Artery Disease
| Article | Year |
|---|---|
Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
Topics: Adult; Aged; Aged, 80 and over; Cognition Disorders; Coronary Artery Bypass; Coronary Artery Disease | 2003 |